title: Alpha and beta thalassemia.
abstract: The thalassemias are a group of inherited hematologic disorders caused by defects in the synthesis of one or more of the hemoglobin chains. Alpha thalassemia is caused by reduced or absent synthesis of alpha globin chains, and beta thalassemia is caused by reduced or absent synthesis of beta globin chains. Imbalances of globin chains cause hemolysis and impair erythropoiesis. Silent carriers of alpha thalassemia and persons with alpha or beta thalassemia trait are asymptomatic and require no treatment. Alpha thalassemia intermedia, or hemoglobin H disease, causes hemolytic anemia. Alpha thalassemia major with hemoglobin Bart's usually results in fatal hydrops fetalis. Beta thalassemia major causes hemolytic anemia, poor growth, and skeletal abnormalities during infancy. Affected children will require regular lifelong blood transfusions. Beta thalassemia intermedia is less severe than beta thalassemia major and may require episodic blood transfusions. Transfusion-dependent patients will develop iron overload and require chelation therapy to remove the excess iron. Bone marrow transplants can be curative for some children with beta thalassemia major. Persons with thalassemia should be referred for preconception genetic counseling, and persons with alpha thalassemia trait should consider chorionic villus sampling to diagnose infants with hemoglobin Bart's, which increases the risk of toxemia and postpartum bleeding. Persons with the thalassemia trait have a normal life expectancy. Persons with beta thalassemia major often die from cardiac complications of iron overload by 30 years of age.
authors.affiliation: Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA. hmunci@lsuhsc.edu
authors.forename: Herbert L
authors.initials: HL
authors.lastname: Muncie
authors.forename: James
authors.initials: J
authors.lastname: Campbell
mesh_terms: D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D015913:Chelation Therapy; D004909:Erythrocyte Indices; D004920:Erythropoiesis / Q000502:physiology; D006454:Hemoglobins / Q000737:chemistry; D006801:Humans; D017085:alpha-Thalassemia / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D017086:beta-Thalassemia / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy
chemical_list: D006454:Hemoglobins